Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
Crossref DOI link: https://doi.org/10.3389/fmed.2022.1020188
Published Online: 2022-12-22
Update policy: https://doi.org/10.3389/crossmark-policy
Pallares, Roger M.
Abergel, Rebecca J.
Funding for this research was provided by:
Lawrence Berkeley National Laboratory
Version of Record valid from 2022-12-22
